Description
ROCKVILLE CENTRE, NY — An innovative lung cancer treatment is available through Rockville Centre's Catholic Health, making it the only New York area health system participating in the clinical trial.
Catholic Health is partnering with Roswell Park Care Network, to study the impact of immunotherapy, CIMAvax-EGF.
It is a type of immunotherapy that uses the body's immune system to fight lung cancer, effectively starving cancer cells of a protein needed for cancer to survive.
"The continued study of immunotherapies to treat both lung and head and neck cancer is veryexciting and holds a great deal of promise for the future," Catholic Health's Chair of Cancer Services, Dr. Bhoomi Mehrotra, said in a statement.
For information on the clinical trials at Catholic Health may be obtained by visiting chsli.org.
Discussion
By posting you agree to the Terms and Privacy Policy.